{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T11:52:01Z","timestamp":1789213921991,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science Foundation Graduate Research Fellowship Program"},{"name":"University of Michigan Musculoskeletal Core Center","award":["AR46024"],"award-info":[{"award-number":["AR46024"]}]},{"name":"regenerative sciences training grant","award":["T90 DK070071"],"award-info":[{"award-number":["T90 DK070071"]}]},{"name":"University of Michigan Department of Orthopaedic Surgery"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AR047969"],"award-info":[{"award-number":["AR047969"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NICHD Intramural Funding"}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.bone.2013.06.003","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T10:32:39Z","timestamp":1371205959000},"page":"204-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Fracture healing with alendronate treatment in the Brtl\/+ mouse model of osteogenesis imperfecta"],"prefix":"10.1016","volume":"56","author":[{"given":"J.A.","family":"Meganck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"Begun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"McElderry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Swick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Kozloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Caird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bone.2013.06.003_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","article-title":"Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans","volume":"28","author":"Marini","year":"2007","journal-title":"Hum Mutat"},{"issue":"12","key":"10.1016\/j.bone.2013.06.003_bb0010","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/humu.20799","article-title":"CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta","volume":"29","author":"Baldridge","year":"2008","journal-title":"Hum Mutat"},{"issue":"14","key":"10.1016\/j.bone.2013.06.003_bb0015","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4161\/cc.6.14.4474","article-title":"Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development","volume":"6","author":"Marini","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bone.2013.06.003_bb0020","unstructured":"Herring JA, ed. Tachdjian's Pediatric Orthopaedics. 3rd ed. 3 vol. Tachdjian MO, series ed. Philadelphia: W.B. Saunders, 2002."},{"issue":"8","key":"10.1016\/j.bone.2013.06.003_bb0025","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1359\/jbmr.070418","article-title":"Natural history of hyperplastic callus formation in osteogenesis imperfecta type V","volume":"22","author":"Cheung","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.bone.2013.06.003_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/01202412-200303000-00002","article-title":"Osteogenesis imperfecta and hyperplastic callus formation in a family: a report of three cases and a review of the literature","volume":"12","author":"Ramirez","year":"2003","journal-title":"J Pediatr Orthop B"},{"issue":"1","key":"10.1016\/j.bone.2013.06.003_bb0035","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000173740","article-title":"Pamidronate treatment of children with moderate-to-severe osteogenesis imperfecta: a note of caution","volume":"71","author":"Alharbi","year":"2009","journal-title":"Horm Res"},{"issue":"6","key":"10.1016\/j.bone.2013.06.003_bb0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.bone.2013.06.003_bb0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S8756-3282(00)00269-6","article-title":"Static and dynamic bone histomorphometry in children with osteogenesis imperfecta","volume":"26","author":"Rauch","year":"2000","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.bone.2013.06.003_bb0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"issue":"Suppl. 3","key":"10.1016\/j.bone.2013.06.003_bb0055","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1007\/BF01623002","article-title":"Clinical pharmacology of alendronate sodium","volume":"3","author":"Gertz","year":"1993","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.bone.2013.06.003_bb0060","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1210\/jc.2004-2054","article-title":"Single-dose pharmacokinetics and tolerability of alendronate 35- and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I","volume":"90","author":"Ward","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.bone.2013.06.003_bb0065","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMc062792","article-title":"Prolonged bisphosphonate release after treatment in children","volume":"356","author":"Papapoulos","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.bone.2013.06.003_bb0070","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1359\/jbmr.080511","article-title":"Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases","volume":"23","author":"Whyte","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.bone.2013.06.003_bb0075","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrendo.2009.58","article-title":"Bone: Use of bisphosphonates in children-proceed with caution","volume":"5","author":"Marini","year":"2009","journal-title":"Nat Rev Endocrinol"},{"issue":"18","key":"10.1016\/j.bone.2013.06.003_bb0080","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.bone.2013.06.003_bb0085","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","article-title":"Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate","volume":"19","author":"Munns","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.bone.2013.06.003_bb0090","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.bpo.0000152940.10487.c9","article-title":"Bone healing in children with osteogenesis imperfecta treated with bisphosphonates","volume":"25","author":"Pizones","year":"2005","journal-title":"J Pediatr Orthop"},{"issue":"9418","key":"10.1016\/j.bone.2013.06.003_bb0095","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bone.2013.06.003_bb0100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1359\/JBMR.041232","article-title":"Intravenous neridronate in children with osteogenesis imperfecta: a randomized controlled study","volume":"20","author":"Gatti","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.bone.2013.06.003_bb0105","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1359\/jbmr.090213","article-title":"Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study","volume":"24","author":"Rauch","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"9419","key":"10.1016\/j.bone.2013.06.003_bb0110","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bone.2013.06.003_bb0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jor.1100140113","article-title":"Effect of alendronate on fracture healing and bone remodeling in dogs","volume":"14","author":"Peter","year":"1996","journal-title":"J Orthop Res"},{"issue":"10","key":"10.1016\/j.bone.2013.06.003_bb0120","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1359\/jbmr.2000.15.10.2042","article-title":"Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats","volume":"15","author":"Li","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.bone.2013.06.003_bb0125","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1359\/jbmr.2002.17.12.2237","article-title":"Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats","volume":"17","author":"Cao","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.bone.2013.06.003_bb0130","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.orthres.2005.03.004","article-title":"A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair","volume":"23","author":"Amanat","year":"2005","journal-title":"J Orthop Res"},{"issue":"6","key":"10.1016\/j.bone.2013.06.003_bb0135","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1359\/jbmr.070318","article-title":"Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair","volume":"22","author":"Amanat","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.bone.2013.06.003_bb0140","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/17453670810016768","article-title":"Local application of zoledronic acid incorporated in a poly(D, l-lactide)-coated implant accelerates fracture healing in rats","volume":"79","author":"Greiner","year":"2008","journal-title":"Acta Orthop"},{"issue":"4","key":"10.1016\/j.bone.2013.06.003_bb0145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bone.2008.05.019","article-title":"Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling","volume":"43","author":"McDonald","year":"2008","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2013.06.003_bb0150","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1359\/jbmr.081113","article-title":"Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing","volume":"24","author":"Gerstenfeld","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.bone.2013.06.003_bb0155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1359\/jbmr.1999.14.6.969","article-title":"Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats","volume":"14","author":"Li","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"53","key":"10.1016\/j.bone.2013.06.003_bb0160","doi-asserted-by":"crossref","first-page":"37923","DOI":"10.1074\/jbc.274.53.37923","article-title":"Use of the Cre\/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution variability in phenotype in BrtlIV mice","volume":"274","author":"Forlino","year":"1999","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.bone.2013.06.003_bb0165","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1359\/JBMR.040111","article-title":"Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength","volume":"19","author":"Kozloff","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"12","key":"10.1016\/j.bone.2013.06.003_bb0170","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1359\/jbmr.080804","article-title":"Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors","volume":"23","author":"Uveges","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.bone.2013.06.003_bb0175","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1359\/jbmr.081238","article-title":"Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation","volume":"24","author":"Uveges","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.bone.2013.06.003_bb0180","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1359\/jbmr.090101","article-title":"Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing","volume":"24","author":"Taylor","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2013.06.003_bb0185","first-page":"v","article-title":"Fracture and dislocation compendium. Orthopaedic Trauma Association Committee for Coding and Classification","volume":"10","year":"1996","journal-title":"J Orthop Trauma"},{"issue":"6","key":"10.1016\/j.bone.2013.06.003_bb0190","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.bone.2009.07.078","article-title":"Beam hardening artifacts in micro-computed tomography scanning can be reduced by X-ray beam filtration and the resulting images can be used to accurately measure BMD","volume":"45","author":"Meganck","year":"2009","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2013.06.003_bb0195","first-page":"291","article-title":"Quantification of histochemical staining by color deconvolution","volume":"23","author":"Ruifrok","year":"2001","journal-title":"Anal Quant Cytol Histol"},{"issue":"10","key":"10.1016\/j.bone.2013.06.003_bb0200","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1359\/JBMR.040709","article-title":"Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis","volume":"19","author":"Smith","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.bone.2013.06.003_bb0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jemt.20551","article-title":"Practical considerations in the use of polarized light microscopy in the analysis of the collagen network in articular cartilage","volume":"71","author":"Rieppo","year":"2008","journal-title":"Microsc Res Tech"},{"issue":"1","key":"10.1016\/j.bone.2013.06.003_bb0210","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1359\/JBMR.050909","article-title":"Decreased collagen organization and content are associated with reduced strength of demineralized and intact bone in the SAMP6 mouse","volume":"21","author":"Silva","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.bone.2013.06.003_bb0215","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00223-002-1039-0","article-title":"Ultrastructural changes accompanying the mechanical deformation of bone tissue: a Raman imaging study","volume":"72","author":"Carden","year":"2003","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"10.1016\/j.bone.2013.06.003_bb0220","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00223-006-0011-9","article-title":"Complementary information on in vitro conversion of amorphous (precursor) calcium phosphate to hydroxyapatite from Raman microspectroscopy and wide-angle X-ray scattering","volume":"79","author":"Kazanci","year":"2006","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"10.1016\/j.bone.2013.06.003_bb0225","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1366\/000370206778664743","article-title":"Identifying chemical changes in subchondral bone taken from murine knee joints using Raman spectroscopy","volume":"60","author":"Dehring","year":"2006","journal-title":"Appl Spectrosc"},{"issue":"6","key":"10.1016\/j.bone.2013.06.003_bb0230","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1359\/jbmr.081259","article-title":"Inbred strain-specific response to biglycan deficiency in the cortical bone of C57BL6\/129 and C3H\/He mice","volume":"24","author":"Wallace","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.bone.2013.06.003_bb0235","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1359\/jbmr.2001.16.10.1821","article-title":"Spectroscopic characterization of collagen cross-links in bone","volume":"16","author":"Paschalis","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"1\u20134","key":"10.1016\/j.bone.2013.06.003_bb0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000151452","article-title":"Exercise alters mineral and matrix composition in the absence of adding new bone","volume":"189","author":"Kohn","year":"2009","journal-title":"Cells Tissues Organs"},{"issue":"8","key":"10.1016\/j.bone.2013.06.003_bb0245","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1359\/jbmr.070504","article-title":"Noninvasive optical detection of bone mineral","volume":"22","author":"Kozloff","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.bone.2013.06.003_bb0250","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2106\/JBJS.F.00726","article-title":"Zebra lines of pamidronate therapy in children","volume":"89","author":"Al Muderis","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.bone.2013.06.003_bb0255","series-title":"Transactions of the 56th annual meeting of the Orthopaedic Research Society (New Orleans, LA). Rosemont, IL: Orthopaedic Research Society","first-page":"461","article-title":"Spatial heterogeneity of bisphosphonate delivery and retention influences local healing of bone in model of disuse osteopenia","author":"Kozloff","year":"2010"},{"key":"10.1016\/j.bone.2013.06.003_bb0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ar.1091500403","article-title":"Fracture callus formation in young and old mice observed with polarized light microscopy","volume":"150","author":"Tonna","year":"1964","journal-title":"Anat Rec"},{"issue":"2","key":"10.1016\/j.bone.2013.06.003_bb0265","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jor.20469","article-title":"The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta","volume":"26","author":"Delos","year":"2008","journal-title":"J Orthop Res"},{"issue":"7","key":"10.1016\/j.bone.2013.06.003_bb0270","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1359\/jbmr.090201","article-title":"Spatial variation in osteonal bone properties relative to tissue and animal age","volume":"24","author":"Gourion-Arsiquaud","year":"2009","journal-title":"J Bone Miner Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213002214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213002214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T04:21:43Z","timestamp":1539577303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328213002214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S8756328213002214"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2013.06.003","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fracture healing with alendronate treatment in the Brtl\/+ mouse model of osteogenesis imperfecta","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2013.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}